“innovation through collaboration”
“taking on the challenges of today, to build a new future for tomorrow”
“rich in knowledge and experience with a vision of a better world”
“what with the future bring?”
“with an eye on the earth and the future”
“where excellence is expected and rewarded”
“making the world our partners to build a brighter and better future”

Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company located in the UK focused primarily on cardiometabolic therapeutics.

It was established in 2000 after the clinical research focused Kowa Research Europe Ltd. had been founded in 1999. These European pharmaceutical divisions of Kowa Company, Ltd. are committed to ground-breaking drug research, development and marketing. Together they seek to ensure quality products are made available to people within Europe and beyond, looking to contribute to a better standard of health and a more comfortable life for all. Find out more.

Latest News

RSS feed

27 Jun 2011
Pitavastatin consistently demonstrates sustained increases in HDL-C
Full Story

27 Jun 2011
New European Atherosclerosis Society’s guidance highlights need to target triglycerides
Full Story

03 May 2011
Livazo® (pitavastatin), a new potent statin with beneficial effects on lipid fractions
Full Story

All News

Our Company

“Kowa is committed to the healthcare global community.”

Our entrepreneurial initiative means we’re determined to meet future needs.

Read more

Products

Products

Since 2003, pitavastatin has accumulated over 4 million patient-years of exposure.

All products